In an interview for NBC News, Vin Gupta, MD, MPA, MSc, affiliate assistant professor of Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) at…
Dileep R. Yavagal, MD, Professor of Neurology & Neurosurgery and Chief Interventional Neurologist at the University of Miami – Miller School of Medicine, describes a treatment that has…
NEW YORK (Reuters Health) – Oral anticoagulation might no longer be necessary after successful atrial fibrillation ablation, not even in patients at moderate-high risk for thromboembolism, a recent…
NEW YORK (Reuters Health) – In treating acute coronary syndromes, a slow response to clopidogrel in the first hour of administration predicts a low response at 24 hours…
NEW YORK (Reuters Health) – While rates of childhood pneumonia have fallen in the U.S., the pediatric pneumonia that does occur is more often complicated by empyema, investigators…
NEW YORK (Reuters Health) – The risk of hip fracture is significantly lower when organic nitrates are used as needed rather than continuously, according to a February 3rd…
NEW YORK (Reuters Health) – In patients with chest pain of uncertain origin, emergency department evaluation combining clinical history and N-terminal pro-B-type natriuretic peptide (NT-proBNP) level, without exercise…
NEW YORK (Reuters Health) – Limiting thyroid tests to high-risk women will miss most cases of thyroid dysfunction during pregnancy, randomized trial results show. Furthermore, when low-risk women…
NEW YORK (Reuters Health) – Triple antiplatelet therapy is more effective than dual therapy at reducing ischemic events after implantation of a drug-eluting stent (DES), according to an…
NEW YORK (Reuters Health) – Potassium monitoring can help prevent drug-associated hyperkalemia events in patients with diabetes, according to a report in the January 20th online issue of…
NEW YORK (Reuters Health) – How intermittent pneumatic compression compares to graduated compression stockings for preventing deep vein thrombosis (DVT) is still unclear, according to a systematic review…
NEW YORK (Reuters Health) – For acute gout flare, a 1-hour low-dose oral colchicine regimen offers comparable efficacy and better tolerability than the more common 6-hour high-dose regimen,…
